Proteomics seeks FDA approval for blood test kit – The West Australian
“FDA sign off would assure potential licensing partners and consumers that the test has been developed and manufactured to US safety, health and environmental protection standards. With CE Mark approval and FDA clearance we would have access to more than 70 per cent of the global IVD diagnostic market.” – Proteomics Managing Director, Dr Richard Lipscombe